TransMedics TMDX
Valuation
Multiples measured against the stock's own five-year history
Above its usual level · 67th percentile, 5-year average 159.9x
#1913 of 2993 stocks by PE (1 = cheapest)
Near the bottom of its 5-year range · 10th percentile, 5-year average 14.3x
#4526 of 5330 stocks by PB (1 = cheapest)
Near the bottom of its 5-year range · 8th percentile, 5-year average 13.9x
#3772 of 5155 stocks by PS (1 = cheapest)
P/E over five years
Dashed line is the 5-year average; the shaded band is one standard deviation either side.
Morningstar fair value estimate
| Multiple | Current | Forward | 5y average | Percentile vs. own history | Industry rank |
|---|---|---|---|---|---|
| PB | 5.76 | – | 14.27 | 10% (cheaper than usual) | #4526 of 5330 (1 = cheapest) |
| PE | 24.90 | 32.53 | 159.86 | 67% (pricier than usual) | #1913 of 2993 (1 = cheapest) |
| PS | 4.36 | 3.69 | 13.94 | 8% (cheaper than usual) | #3772 of 5155 (1 = cheapest) |
Percentile is against this stock’s own 5-year valuation range: higher means it’s trading rich relative to its own history, lower means cheap relative to its own history — it is not a comparison against other companies. Forward multiples use consensus estimates for the next twelve months; a forward multiple below the current one usually signals analysts expect earnings to grow.
No comments yet — be the first to weigh in on TMDX.
Sign in to join the discussion.